1 Richardson LA, El-Zein M, Ramanakumar AV, et al.HPV DNA testing with cytology triage in cervical cancer screening:Influence of revealing HPV infection status[J].Cancer Cytopathol, 2015, 123(12):745-754. 2 Kiseki H, Tsukahara Y, Tajima N, et al.Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance[J].J Infect Chemother, 2017, 23(12):814-819. 3 Boscolo-Rizzo P, Pawlita M, Holzinger D.From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas[J].Cancer Treat Rev, 2016, 42(1):24-29. 4 Walch-Ruckheim B, Mavrova R, Henning M, et al.Stromal fibroblasts induce CCL20 through IL6/C/EBPβ to support the recruitment of Th17 cells during cervical cancer progression[J].Cancer Res, 2015, 75(24):5248-5259. 5 Simone CS, Renata AMR, Aleida ML, et al.HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models[J].Immun Inflamm Dis, 2014, 2(2):63-75. 6 Skinner SR, Wheeler CM, Romanowski B, et al.Progression of HPV infection to detectable cervical lesions or clearance in adult women:Analysis of the control arm of the VIVIANE study[J].Int J Cancer, 2016, 138(10):2428-2438. 7 Koshiol J, Lindsay L, Pimenta JM, et al.Persistent human papilloma virus infection and cervical neoplasia a systematic review and meta-analysis[J].Am J Epidemiol, 2008, 168(2):123-137. 8 Rositch AF, Koshiol J, Hudgens MG, et al.Patterns of persistent genital papillomavirus infection among women world-wide:a literature review and meta-analysis[J].Int J Cancer, 2013, 133(6):1271-1285. 9 Trinchieri G.Cancer immunity:lessons from infectious diseases[J].J Infect Dis, 2015, 212(Suppl 1):67-73. 10 赵敏伊, 赵娟, 杨婷, 等.免疫因子表达异常促进宫颈癌微环境免疫失衡[J].中国医学科学院学报, 2016, 38(5):522-527. 11 Poggi A, Giuliani M.Mesenchymal stromal cells can regulate the immune response in the tumor microenvironment[J].Vaccines(Basel), 2016, 4(4):41-62. 12 Hong JH, Kim MK, Lee IH, et al.Association between serum cytokine profiles and clearance or persistence of high-risk human papillomavirus infection:a prospective study[J].Int J Gynecol Cancer, 2010, 20(6):1011-1016. 13 Tang H, Qiao J, Fu YX.Immunotherapy and tumor microenvironment[J].Cancer Lett, 2016, 370(1):85-90. 14 Daniilidis A, Koutsos J, Oikonomou Z, et al.Cytokines of cervical mucosa and human papilloma virus infection of the cervix:A descriptive study[J].Acta Cytologica, 2016, 60(1):58-64. 15 Rakhra K, Bachireddy P, Zabuawala T, et al.CD4(+)T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation[J].Cancer Cell, 2010, 18(5):485-498. 16 Gosmann C, Mattarollo SR, Bridge JA, et al.IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia[J].J Immunol, 2014, 193(5):2248-2257. 17 Egawa N, Egawa K, Griffin H, et al.Human papillomaviruses;epithelial Tropisms, and the development of neoplasia[J].Viruses, 2015, 7(7):3863-3890. 18 Fernandes JV, Medeiros Fernandes TA, DE Azevedo JC, et al.Link between chronic inflammation and human papillomavirus-induced carcinogenesis(Review)[J].Oncol Lett, 2015, 9(3):1015-1026. |